Prostatis Group LLC has filed its 13F form on November 04, 2025 for Q3 2025 where it was disclosed a total value porftolio of $399 Billion distributed in 165 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Thor Finl Technologies Tr with a value of $70.3B, Amplify ETF Tr Amplify Cwp Enh with a value of $20.4B, Invesco Qqq Trust, Series 1 with a value of $19.4B, Vanguard Growth ETF with a value of $11.3B, and Spdr Series Trust Spdr Nyse Te with a value of $10.2B.

Examining the 13F form we can see an increase of $49.6B in the current position value, from $349B to 399B.

Prostatis Group LLC is based out at Hanover, MD

Below you can find more details about Prostatis Group LLC portfolio as well as his latest detailed transactions.

Portfolio value $399 Billion
ETFs: $243 Billion
Technology: $21.9 Billion
Consumer Cyclical: $10.5 Billion
Communication Services: $8.89 Billion
Industrials: $6.71 Billion
Financial Services: $5.57 Billion
Energy: $3.22 Billion
Healthcare: $2.51 Billion
Other: $4.25 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 165
  • Current Value $399 Billion
  • Prior Value $349 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 04, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 17 stocks
  • Additional Purchases 75 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 68 stocks
Track This Portfolio

Track Prostatis Group LLC Portfolio

Follow Prostatis Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.